Drug Side Effects
Search
ERYTHROPHAGOCYTOSIS
ERYTHROPHAGOCYTOSIS
was reported 23 times
ERYTHROPHAGOCYTOSIS is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Lipid-based Polyene Antifungal [EPC]
3
0.0002
1
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
5
0.0002
2
Quinolone Antimicrobial [EPC]
1
0.0001
3
Penem Antibacterial [EPC]
3
0.0001
4
Polyene Antifungal [EPC]
3
0.0001
5
CD52-directed Cytolytic Antibody [EPC]
1
0.0001
6
Glycopeptide Antibacterial [EPC]
3
0.0000
7
Bile Acid [EPC]
1
0.0000
8
Iron Chelator [EPC]
1
0.0000
9
Methylxanthine [EPC]
1
0.0000
10
BCL-2 Inhibitor [EPC]
1
0.0000
11
Calcineurin Inhibitor Immunosuppressant [EPC]
2
0.0000
12
Tetracycline-class Drug [EPC]
1
0.0000
13
Cardiac Glycoside [EPC]
1
0.0000
14
Topoisomerase Inhibitor [EPC]
1
0.0000
15
Kinase Inhibitor [EPC]
7
0.0000
16
Nucleoside Analog Antiviral [EPC]
1
0.0000
17
Central Nervous System Stimulant [EPC]
1
0.0000
18
Purine Antimetabolite [EPC]
1
0.0000
19
Fluoroquinolone Antibacterial [EPC]
1
0.0000
20
Leukocyte Growth Factor [EPC]
1
0.0000
21
Corticosteroid [EPC]
9
0.0000
22
Janus Kinase Inhibitor [EPC]
1
0.0000
23
Expectorant [EPC]
1
0.0000
24
Folate Analog Metabolic Inhibitor [EPC]
2
0.0000
25
Angiotensin 2 Receptor Blocker [EPC]
1
0.0000
26
HMG-CoA Reductase Inhibitor [EPC]
1
0.0000
27
Nonsteroidal Anti-inflammatory Drug [EPC]
3
0.0000
28
Tumor Necrosis Factor Blocker [EPC]
2
0.0000
29
Proton Pump Inhibitor [EPC]
1
0.0000
30
Benzodiazepine [EPC]
1
0.0000